Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

BACKGROUND: Checkpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs). However, the roles played by peripheral blood parameters in CIP development remain unclear. Here, we aimed to identify...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Oncol
Glavni autori: Lin, Xinqing, Deng, Haiyi, Yang, Yilin, Wu, Jianhui, Qiu, Guihuan, Li, Suyang, Xie, Xiaohong, Liu, Ming, Xie, Zhanhong, Qin, Yinyin, Song, Yong, Zhou, Chengzhi
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313853/
https://ncbi.nlm.nih.gov/pubmed/34327140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.698832
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items